XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Business Description (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 22, 2023
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
subsidiary
shares
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2023
USD ($)
subsidiary
shares
Sep. 30, 2022
USD ($)
shares
Sep. 20, 2023
$ / shares
Jun. 30, 2023
shares
Dec. 31, 2022
shares
Jun. 30, 2022
shares
Dec. 31, 2021
shares
Subsidiary, Sale of Stock [Line Items]                    
Number of wholly-owned subsidiaries | subsidiary   3   3            
Underwriting discounts and commissions | $ $ 17,700                  
Offering-related expenses | $ $ 7,600 $ 25,278 $ 307 $ 25,278 $ 307          
Share-based compensation expense recognized | $   301,192 $ 522 303,534 $ 6,245          
Decrease for shares withheld for taxes | $   70,165   70,165            
Issuance of common stock upon exercise of common stock warrants (in shares) 3,935,793                  
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement                    
Subsidiary, Sale of Stock [Line Items]                    
Increase in prepaid marketing expense | $   92,600                
IPO                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued (in shares) 19,200,000                  
Issuance price per share (in dollars per share) | $ / shares $ 30.00         $ 30.00        
Aggregate proceeds, net of discounts and commissions | $ $ 319,900                  
IPO and Over-Allotment Option                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued (in shares) 11,507,693                  
IPO and Over-Allotment Option - Shares From Existing Shareholders                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued (in shares) 7,692,307                  
Additional Paid-In Capital                    
Subsidiary, Sale of Stock [Line Items]                    
Decrease for shares withheld for taxes | $   $ 70,163   $ 70,163            
Series A Common Stock                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, outstanding (in shares)   32,740,767   32,740,767       0    
Series A Common Stock | Conversion of Redeemable Common Stock Into Series B Common Stock                    
Subsidiary, Sale of Stock [Line Items]                    
Conversion of common stock (in shares) 64,046,223                  
Series A Common Stock | Common Stock                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, outstanding (in shares)   32,740,767 0 32,740,767 0   0 0 0 0
Series A Common Stock | Common Stock | Conversion of Common Stock Upon Initial Public Offering                    
Subsidiary, Sale of Stock [Line Items]                    
Conversion of common stock (in shares)   21,233,074   21,233,074            
Series B Common Stock                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, outstanding (in shares)   225,557,191   225,557,191       170,855,313    
Shares withheld for taxes (in shares)   2,350,702   2,350,702            
Series B Common Stock | Common Stock                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, outstanding (in shares)   225,557,191 169,973,398 225,557,191 169,973,398   173,222,733 170,855,313 163,007,686 161,756,287
Decrease for shares withheld for taxes | $   $ 2   $ 2            
Issuance of common stock upon exercise of common stock warrants (in shares)   4,526,162 3,935,793 5,706,904 3,935,793          
Series B Common Stock | Common Stock | Conversion of Common Stock Upon Initial Public Offering                    
Subsidiary, Sale of Stock [Line Items]                    
Conversion of common stock (in shares)   (21,233,074)   (21,233,074)